PRESS RELEASE published on 04/02/2026 at 18:00, 4 months 3 days ago 2025 Annual Results: Strong sales growth, expansion of the customer portfolio and BioSolutions, and strengthening of the financial structure thanks to Huvepharma Fermentalg reports a record 2025 turnover of €13.4 million, stable operating profit, post-closing loan from Huvepharma, promising outlook with new product launches, and a target of €20 million revenue by 2026 Product Launches Revenue Target FERMENTALG 2025 Turnover Huvepharma Loan
BRIEF published on 03/16/2026 at 11:05, 4 months 21 days ago EFSA gives green light to Fermentalg's Galdieria Blue colorant Marketing FERMENTALG Microalgae EFSA Galdieria Blue
BRIEF published on 03/16/2026 at 11:05, 4 months 21 days ago EFSA Approves Fermentalg’s Natural Blue Colorant for European Market Commercialization FERMENTALG EFSA Galdieria Blue Food Additive
PRESS RELEASE published on 03/16/2026 at 11:00, 4 months 21 days ago EFSA's favorable opinion on Fermentalg's Galdieria Blue colorant paves the way for its commercialization in Europe EFSA approves Fermentalg's natural blue colorant, opening doors for European market. Regulatory approvals signify progress towards global deployment in food and health sectors European Market Regulatory Approvals EFSA Global Deployment Natural Blue Colorant
BRIEF published on 03/04/2026 at 18:05, 5 months 1 day ago FERMENTALG: Information on voting rights and shares Share Capital Voting Rights Euronext Growth FERMENTALG Microalgae
BRIEF published on 02/27/2026 at 18:50, 5 months 6 days ago New liquidity contract for Fermentalg with Portzamparc Liquidity Contract AMF PORTZAMPARC Euronext Growth FERMENTALG
BRIEF published on 02/05/2026 at 18:05, 6 months ago FERMENTALG: Total number of voting rights and shares as of January 31, 2026 Share Capital Voting Rights AMF Regulations Fermentalg Actions Aquatic Microorganisms
BRIEF published on 01/28/2026 at 07:35, 6 months 9 days ago Fermentalg Reports 17% Revenue Growth in 2025, Eyes Further Expansion in 2026 Revenue Growth Product Launches BioSolutions Huvepharma Investment 2026 Expansion
BRIEF published on 01/28/2026 at 07:35, 6 months 9 days ago Fermentalg announces 17% growth and promising prospects for 2026 Innovation Revenue Financial Support Partnerships BioSolutions
PRESS RELEASE published on 01/28/2026 at 07:30, 6 months 9 days ago 17% increase in revenue in 2025, strong acceleration expected in 2026 and financing for the business secured Fermentalg achieved a record revenue of €13.4 million in 2025, exceeding forecasts. New BioSolutions launched, aiming for €20 million revenue in 2026 and €50 million long term, with strong financial support from partner Huvepharma Partnership Financial Support Record Revenue FERMENTALG BioSolutions
Published on 08/06/2026 at 14:30, 31 minutes ago Loar Holdings Inc. Reports Q2 2026 Record Results and Upward Revision to 2026 Outlook
Published on 08/06/2026 at 14:30, 31 minutes ago NV Gold Announces Expansion of Holdings and Drill Program at the Slumber Gold Project in Nevada
Published on 08/06/2026 at 14:30, 31 minutes ago AIAI Holdings' MediGuide Launches Longevity Intelligence, Redefining Personalized Preventive Healthcare
Published on 08/06/2026 at 14:00, 1 hour 1 minute ago Adcore to Publish Second Quarter 2026 Results on August 13, 2026
Published on 08/06/2026 at 14:00, 1 hour 1 minute ago Aeonian Reports Final Drill Results from Jake Target and Advances District-Scale Copper Exploration Model at Koocanusa
Published on 08/06/2026 at 14:40, 21 minutes ago Acceptance Period Commences: Persistent Publishes Public Takeover Offer for all Nagarro Shares
Published on 08/06/2026 at 14:35, 26 minutes ago Eightco Holdings (NASDAQ: ORBS) Reports Total Holdings of Approximately $378 Million, Includes OpenAI, Beast Industries, More Than 16,000 ETH and Nearly 302 Million WLD Tokens
Published on 08/06/2026 at 14:01, 1 hour ago Original-Research: DEUTZ AG (von Quirin Privatbank Kapitalmarktgeschäft): BUY
Published on 08/06/2026 at 08:00, 7 hours 1 minute ago EURAZEO ENTERS INTO EXCLUSIVE DISCUSSIONS WITH PARTNERS GROUP REGARDING THE CONTEMPLATED SALE OF ITS STAKE IN AROMA-ZONE AND ITS REINVESTMENT
Published on 08/05/2026 at 18:00, 21 hours 1 minute ago Information concerning the total number of voting rights and shares in the share capital as of July 31, 2026
Published on 08/05/2026 at 17:49, 21 hours 11 minutes ago Mersen: Number of shares and voting rights as of July 31, 2026
Published on 08/05/2026 at 17:45, 21 hours 16 minutes ago Information concerning the total number of voting rights and shares 2026 07 31
Published on 08/05/2026 at 17:45, 21 hours 16 minutes ago MONTHLY INFORMATION RELATING TO THE TOTAL NUMBER OF VOTING RIGHTS AND SHARES MAKING UP THE SHARE CAPITAL